Acne severity and the Global Acne Grading System in polycystic ovary syndrome (Q45195258)

10 December 2017

title

Acne severity and the Global Acne Grading System in polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

10 December 2017

main subject

1 reference

1 reference

Servet Hacivelioglu

1

1 reference

10 December 2017

Ayse Nur Cakir Gungor

2

1 reference

10 December 2017

Meryem Gencer

3

1 reference

10 December 2017

Ahmet Uysal

4

1 reference

10 December 2017

Deniz Hizli

5

1 reference

10 December 2017

Evrim Koc

6

1 reference

10 December 2017

Emine Cosar

7

1 reference

10 December 2017

language of work or name

1 reference

12 August 2013

1 reference

International Journal of Gynecology and Obstetrics

10 December 2017

published in

1 reference

10 December 2017

volume

123

1 reference

10 December 2017

issue

1

1 reference

10 December 2017

page(s)

33-36

1 reference

Androgen excess in women: experience with over 1000 consecutive patients

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2013.05.005

Acne analysis, grading and computational assessment methods: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2013.05.005

Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2013.05.005

Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2013.05.005

Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2013.05.005

Dermatologic manifestations of polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2013.05.005

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2013.05.005

The role of androgens in determining acne severity in adult women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2013.05.005

Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2013.05.005

The Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (PCOSQ): a validation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2013.05.005

Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2013.05.005

Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2013.05.005

Hyperandrogenemia in patients presenting with acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2013.05.005

Adolescent polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2013.05.005

Prevalence of polycystic ovaries in women with androgenic alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2013.05.005

10.1016/J.IJGO.2013.05.005

21 January 2018

Identifiers

DOI

1 reference

10 December 2017

1 reference